Clinical trials
Ischemic Stroke clinical trials
Below are recruiting ischemic stroke clinical trials, each written for real people, not researchers. We’re tracking 579 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05065216RecruitingPhase 2/Phase 3
Study drug for acute ischemic stroke started within 24 hours
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
Fairhope, AlabamaAges 18–90 - NCT07003386RecruitingPhase 2/Phase 3
Galantamine for recent ischemic stroke
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07731087Recruiting
Stem cell secretion therapy for thinking recovery after stroke
This study tests whether a therapy made from stem cell secretions can help improve memory and thinking after an ischemic stroke. It is for people who had a clot-related stroke in the past 3 months and now have mild to moderate cognitive issues.
Makassar, South SulawesiAges 40–75 - NCT07405762Recruiting
Stroke recovery after blood clot removal: brain blood flow study
This trial looks at how blood flow and brain activity change in the first days after a stroke caused by a large blockage in the front part of the brain. It tests if certain patterns can help predict recovery after a procedure to remove the clot.
Xi'an, Shan'xiAges 18–85 - NCT07347665Recruiting
Endovascular therapy for M2 segment stroke
This study tests whether a minimally invasive procedure to remove a blood clot from a specific branch of a brain artery (the M2 segment) helps people recover from a stroke better than standard care alone. It is for people who have had a moderate to severe stroke within the past 24 hours and could not get clot-dissolving medicine or it didn't work.
Nishinomiya, HyōgoAges 18–84 - NCT03318432Recruiting
Stroke recovery research registry for people with ongoing symptoms
This study is a registry that enrolls adults who have had a stroke and still have symptoms. It helps researchers learn about stroke recovery over time and may connect you to future stroke research studies.
San Francisco, CaliforniaAges 18 years+ - NCT03710902Recruiting
Mobile coaching to lower heart risk after stroke
This trial tests whether a mobile technology program can help people manage risk factors like high blood pressure after an ischemic stroke or a “mini-stroke” (TIA). It may help lower future cardiovascular risks by improving day-to-day control of these conditions.
HämeenlinnaAges 40 years+ - NCT04175691Recruiting
Study blood RNA markers after sudden ischemic stroke
This trial looks at blood “RNA markers” (molecules that may reflect brain injury) in people who have had a new ischemic stroke. It may help doctors understand what’s happening in the body soon after stroke and possibly guide future care.
Nanjing, JiangsuAges 18 years+ - NCT04412187Recruiting
Study of inflammation after a new stroke
This study looks at inflammation-related changes soon after an acute ischemic stroke (a type caused by a blocked blood vessel). It may help researchers understand what factors drive recovery and how they could be targeted in the future.
Munich, GermanyAges 50 years+ - NCT04824482Recruiting
Robot training to improve walking after a recent stroke
This study tests a robot-assisted walking program for people recovering after an acute ischemic stroke. It aims to improve how safely and independently you can walk during recovery.
OlomoucAges 18–80 - NCT04956185Recruiting
Collecting hospital data from people with stroke
This study collects information from people admitted to the stroke care team or neurology during their hospital stay. It may help improve stroke care by understanding patient conditions and hospital experiences.
Ghent, FlandersAges Any age - NCT05024292Recruiting
Alliance study for acute stroke after clot removal
This trial tests a stroke treatment plan for adults after they have a clot removed by a catheter procedure (endovascular treatment). It focuses on people with certain artery blockages and specific scan results, aiming to improve recovery after successful clot removal.
Zhangzhou, FujianAges 18–95 - NCT05051397RecruitingPhase 2
Breathing gas study during clot removal for stroke
This Phase 2 trial tests whether changing breathing gas (CO₂ level) during a mechanical procedure to remove a brain blood clot can improve outcomes for acute ischemic stroke. It may help by protecting the brain during the clot-removal procedure under general anesthesia.
Clermont-FerrandAges 18 years+ - NCT05199194RecruitingPhase 3
Clot-busting before or during procedure for acute stroke
This study compares two treatment approaches for a stroke caused by a blocked brain artery: doing a procedure to remove the clot alone versus giving an IV clot-busting medicine first (tenecteplase). It aims to see which approach works better and is safest for improving recovery.
Porto Alegre, Rio Grande do SulAges 18–85 - NCT05281055Recruiting
Registry of clot-removal treatment for sudden large-vessel strokes
This study keeps a record of people treated with a clot-removal procedure (endovascular thrombectomy) for a sudden stroke caused by a blocked large blood vessel in the brain. It focuses on outcomes for patients who can be treated within 24 hours and were independent before the stroke.
TaipeiAges 20 years+ - NCT05281887Recruiting
Study of eye changes after ischemic stroke
This trial looks at how changes in the retina (the light-sensing tissue in the back of the eye) track with vision and eye function after an ischemic stroke. The goal is to understand which eye changes are linked to the stroke, which could help doctors monitor recovery.
Guangzhou, GuangdongAges 18 years+ - NCT05300997Recruiting
Test blood and antibody markers for suspected acute stroke
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
Hong KongAges 18–100 - NCT05476991RecruitingPhase 3
Low-dose colchicine plus ticagrelor to prevent repeat stroke
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
Paris, ParisAges 18 years+ - NCT05494034Recruiting
Monitoring heart rhythms after stroke to guide care
This study uses a small implantable heart monitor to track heart rhythm in people after an acute ischemic stroke or TIA. It aims to learn how often hidden heart rhythm problems show up, which could help doctors choose better stroke prevention treatments.
AthensAges 40–100 - NCT05518305Recruiting
Predicting recurrent stroke risk in people with artery narrowing
This study looks at blood markers and brain/artery scan results to predict who with intracranial artery narrowing is more likely to have another stroke. It may help doctors spot higher-risk people earlier and better target prevention.
Los Angeles, CaliforniaAges 30 years+ - NCT05561088Recruiting
Head acupuncture after stroke clot removal
This trial studies whether doing head acupuncture after a procedure to remove a stroke-causing blood clot can improve recovery and safety. You may be considered if you had endovascular clot removal within 24 hours and meet specific brain-scan and stroke-severity measures.
Xi'an, ShaanxiAges 18–100 - NCT05578300Recruiting
Translating thrombectomy care into real-world practice in Asia-Pacific
This study aims to help endovascular thrombectomy for certain severe strokes work well in everyday hospital care across Asia-Pacific. You may be considered if you’re an adult with a specific type of stroke blocked in a major brain blood vessel.
Linyi, ShandongAges 18 years+ - NCT05691244RecruitingPhase 3
Tested drug for acute ischemic stroke within 24 hours
This Phase 3 trial studies sovateltide (and a placebo) in adults with an ischemic stroke, aiming to improve safety and outcomes. It focuses on people who can start treatment quickly after stroke symptoms begin and who do not have bleeding in the brain on imaging.
Tucson, ArizonaAges 18–80 - NCT05789823RecruitingPhase 2
Balloon post-treatment after clot removal in stroke
This trial tests whether a special balloon treatment started after successful clot removal can improve recovery after an acute stroke. It may help some people by protecting the brain during the procedure and early aftermath.
Tianjin, Tianjin MunicipalityAges 18 years+
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Ischemic Stroke trials by city
Studies with a site in or near these metro areas.
Ischemic Stroke trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for ischemic stroke?
- Yes. Clin2 currently lists 579 recruiting ischemic stroke studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic stroke trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic stroke trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.